vs
Side-by-side financial comparison of CRISPR Therapeutics AG (CRSP) and 10x Genomics, Inc. (TXG), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. I...
10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.
| Q4 25 | $864.0K | — | ||
| Q3 25 | $889.0K | — | ||
| Q2 25 | $892.0K | — | ||
| Q1 25 | $865.0K | — | ||
| Q4 24 | $35.7M | — | ||
| Q3 24 | $602.0K | — | ||
| Q2 24 | $517.0K | — | ||
| Q1 24 | $504.0K | — |
| Q4 25 | $-130.6M | — | ||
| Q3 25 | $-106.4M | — | ||
| Q2 25 | $-208.5M | — | ||
| Q1 25 | $-136.0M | — | ||
| Q4 24 | $-37.3M | — | ||
| Q3 24 | $-85.9M | — | ||
| Q2 24 | $-126.4M | — | ||
| Q1 24 | $-116.6M | — |
| Q4 25 | -17912.5% | — | ||
| Q3 25 | -14854.8% | — | ||
| Q2 25 | -25709.0% | — | ||
| Q1 25 | -17158.8% | — | ||
| Q4 24 | -181.0% | — | ||
| Q3 24 | -18294.0% | — | ||
| Q2 24 | -29257.3% | — | ||
| Q1 24 | -27894.2% | — |
| Q4 25 | -15117.2% | — | ||
| Q3 25 | -11973.1% | — | ||
| Q2 25 | -23379.9% | — | ||
| Q1 25 | -15722.1% | — | ||
| Q4 24 | -104.5% | — | ||
| Q3 24 | -14276.1% | — | ||
| Q2 24 | -24450.3% | — | ||
| Q1 24 | -23133.1% | — |
| Q4 25 | $-1.32 | — | ||
| Q3 25 | $-1.17 | — | ||
| Q2 25 | $-2.40 | — | ||
| Q1 25 | $-1.58 | — | ||
| Q4 24 | $-0.41 | — | ||
| Q3 24 | $-1.01 | — | ||
| Q2 24 | $-1.49 | — | ||
| Q1 24 | $-1.43 | — |
Financial Flow Comparison
Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.
